Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.22B | 2.19B | 2.01B | 2.24B | 1.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.22B | 2.19B | 2.01B | 2.24B | 1.94B |
| Cost of Revenue | 1.48B | 1.46B | 1.36B | 1.58B | 1.34B |
| Gross Profit | 739.00M | 731.99M | 644.65M | 660.12M | 598.41M |
| SG&A Expenses | 576.97M | 564.79M | 521.36M | 521.67M | 466.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.19M | 1.13M | 36.62M | -- | -564.00K |
| Total Operating Expenses | 2.06B | 2.02B | 1.92B | 2.10B | 1.81B |
| Operating Income | 158.84M | 166.06M | 86.66M | 138.45M | 132.39M |
| Income Before Tax | 97.47M | 104.98M | 24.08M | 56.14M | 83.07M |
| Income Tax Expenses | 18.01M | 22.58M | -3.89M | 2.34M | 15.22M |
| Earnings from Continuing Operations | 79.45M | 82.40M | 27.97M | 53.80M | 67.85M |
| Earnings from Discontinued Operations | -2.90K | 1.64M | 2.22M | -- | 16.93M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 2.66M | -1.42M |
| Net Income | 79.45M | 84.04M | 30.19M | 56.46M | 83.37M |
| EBIT | 158.84M | 166.06M | 86.66M | 138.45M | 132.39M |
| EBITDA | 201.86M | 207.48M | 125.90M | 188.37M | 166.81M |
| EPS Basic | 0.05 | 0.05 | 0.02 | 0.04 | 0.05 |
| Normalized Basic EPS | 0.04 | 0.04 | 0.01 | 0.03 | 0.03 |
| EPS Diluted | 0.05 | 0.05 | 0.02 | 0.04 | 0.05 |
| Normalized Diluted EPS | 0.04 | 0.04 | 0.01 | 0.03 | 0.03 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.55B | 1.68B |
| Average Diluted Shares Outstanding | 1.67B | 1.68B | 1.69B | 1.55B | 1.69B |
| Dividend Per Share | -- | -- | -- | 0.03 | 0.01 |
| Payout Ratio | -- | 58.02% | 0.31% | 112.92% | 0.02% |